One of the therapeutic strategies for TTR-related amyloidosis aims at stabilizing the TTR tetrameric fold using small molecules which can either i) bind the T4 binding central channel or ii) bind outside the T4 binding channel. This evidence concerns the gene TTR and amyloidosis.